The VIP3 (Very Old Intensive Care Patients) Study: Family Involvement in Treatment Decisions for Old ICU Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age75+
SponsorSt George's, University of London

About this trial

The demographics of the global population is changing with increasing numbers of elderly and co-morbid patients. As a result, more elderly patients will be admitted to the Intensive Care Unit (ICU), which will bring several ethical challenges. It is for this reason the investigators have chosen to focus on this historically neglected and important patient population.

Little is known about how family meetings are implemented in ICUs in Europe and other parts of the world. However, these meetings contribute to building trust between the family and the ICU team. They are a crucial component for planning and conducting a time limited trials as they provide the opportunity for shared-decision making with the ICU team and with other stakeholders.

The investigators plan to determine the current practice of communication between ICU staff and patients and their relatives. The investigators expect to find a substantial variation in approaches to family meetings. This information may then help design and further investigate targeted interventions enabling shared decision-making focused on family and patient values.

The investigators research aim is to to investigate whether Family meetings are used in ICUs across Europe and other regions and, if so, how they are conducted and the influence on patient-centred outcome measures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients admitted to the Intensive Care Unit (ICU) of participating centres

Age 75 years and above

Expected Length of stay (LOS) > 3 days

Disqualifiers

Refusal to participate

Limitation of treatment upon ICU arrival (other than Cardiopulmonary Resuscitation-CPR)

Planned admission

Trial population

Emergency patients admitted to the intensive care unit age 75 years and older. The investigators will ask participating ICUs to include the first consecutive 20 patients or all patients (if \<20) admitted within a 6 month period.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants
are grouped into 1 trial group
Group A: Patients age 75 and above admitted as an emergency to Intensive Care

Trial outcomes

Primary outcomes

1

Number of patients with a structured/planned family meeting

The number of patients that have a family meeting during the intensive care stay

Time frame
Until Intensive care unit (ICU) discharge

Secondary outcomes

1

Median day since Intensive care unit (ICU) admission when the family meeting took place

Day number on ICU when family meeting took place

Time frame
Until ICU discharge
2

Number of people present in the Family Meeting

The total number of participants in the family meeting

Time frame
Until ICU discharge
3

Categorical description of people present in the Family Meeting

What were the roles of the participants in the family meeting (patient relatives, doctors, nurses, other health professionals.)

Time frame
Until ICU discharge
4

The treatment level after the family meeting

Treatment level category decided upon at the end of the family meeting which will be either: continuation of care, therapy reduced due to improvement, therapy withheld (WH), therapy withdrawn (WD).

Time frame
Until ICU discharge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.